Wearables meet neurology
- The American Academy of Neurology issued guidance on using smartwatch and ring data in clinical care. - The guidance highlights devices such as smartwatches and Oura rings as potentially useful when interpreted with physicians. - NPR reported this as part of a trend toward integrating consumer wearable metrics into medical decision-making (npr.org).
A neurologists’ group says data from smartwatches, fitness trackers and smart rings can help care — if doctors review the numbers and their limits. (aan.com) The American Academy of Neurology published the guidance on March 11, 2026, in *Neurology* as an “Emerging Issues in Neurology” article on non-Food and Drug Administration-cleared wearable technology. The group said these articles offer expert-consensus advice for fast-moving topics where the formal evidence base is still evolving. (aan.com 1) (aan.com 2) Wearables collect round-the-clock signals such as heart rate, activity and sleep, and some devices can flag possible atrial fibrillation, seizures or headaches. The academy said those readings can add more complete day-to-day data for people with neurological diseases, but false alarms and false reassurance remain risks. (aan.com) The guidance draws a line between consumer gadgets and diagnosis. The academy said neurologists should discuss limits such as inaccurate readings, anxiety from constant monitoring and how long a patient needs to wear a device for the data to be useful. (aan.com) That caution matches federal labeling on some wearable heart tools. Food and Drug Administration documents for over-the-counter electrocardiogram and rhythm-notification features say users should not take clinical action without consulting a qualified health professional and that the tools are not a replacement for traditional diagnosis or treatment. (fda.gov 1) (fda.gov 2) Smart rings are part of the same shift from wellness tracking to clinician review. Oura says its ring tracks sleep, stress, activity and more than 50 health and wellness metrics, and a January 12, 2026 partnership with Fullscript said more than 125,000 providers on that platform would be able to view opted-in Oura trend data inside clinical workflows. (ouraring.com) (prnewswire.com) Neurology researchers are already testing whether those streams can predict change earlier than office visits do. In a March 4, 2026 study in *Neurology*, researchers followed 238 people with multiple sclerosis for an average of three years and found that declines in daytime activity were linked to worsening disability and loss of brain volume. (aan.com) The academy’s guidance is not a formal practice guideline and does not set a standard of care. It tells neurologists to treat wearable data as one more input — useful when it is checked against symptoms, exams and follow-up testing, not a verdict from a wrist or a ring. (aan.com)
